Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile
Neeraj Agarwal, MD, FASCO

@neerajaiims

Medical Oncologist. Editor-in-chief: @ASCO Daily News; Presidential Endowed Chair, @HuntsmanCancer (NCI-CCC) @UUtah, FCOI bit.ly/3A3u2KL

ID: 4761682514

linkhttps://bit.ly/3JApRJd calendar_today15-01-2016 06:32:10

13,13K Tweet

15,15K Followers

770 Following

Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo
Neeraj Agarwal, MD, FASCO
@neerajaiims

2 years ago

#AUA23 Amer. Urol. Assn. 👉comparing the complete response (CR) rates of TAR-200 with reported CR rates of Pembrolizumab vs Nadofaregene F👉TAR-200 may become new SOC in near future. Great AE profile. OncoAlert UroToday.com Bladder Cancer Advocacy Network

#AUA23 <a href="/AmerUrological/">Amer. Urol. Assn.</a> 👉comparing the complete response (CR) rates of TAR-200 with reported CR rates of Pembrolizumab vs Nadofaregene F👉TAR-200 may become new SOC in near future. Great AE profile. <a href="/OncoAlert/">OncoAlert</a> <a href="/urotoday/">UroToday.com</a> <a href="/BladderCancerUS/">Bladder Cancer Advocacy Network</a>